Log in to save to my catalogue

A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation

A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89af4d5bd2e649eeb96d5d0a32f25537

A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation

About this item

Full title

A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-05, Vol.13 (1), p.7865-7865, Article 7865

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Mucopolysaccharidosis type II (MPS II) is a lysosomal storage disorder characterized by an accumulation of glycosaminoglycans (GAGs), including heparan sulfate, in the body. Major manifestations involve the central nerve system (CNS), skeletal deformation, and visceral manifestations. About 30% of MPS II is linked with an attenuated type of disease...

Alternative Titles

Full title

A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_89af4d5bd2e649eeb96d5d0a32f25537

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89af4d5bd2e649eeb96d5d0a32f25537

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-34541-w

How to access this item